ReviewEuropean journal of nuclear medicine and molecular imaging2019
Why imaging data alone is not enough: AI-based integration of imaging, omics, and clinical data.
Review in European journal of nuclear medicine and molecular imaging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
55 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A systematic review exploring the association between the human gut microbiota and brain connectivity in health and disease.Molecular psychiatry · 2023Pooled it
- Radiology research platform: automating multicenter radiological research workflows using a cloud-native platform.European radiology · 2026Article
- Artificial Intelligence Applications in MRI for the Diagnosis and Management of Osteonecrosis of the Femoral Head: A Comprehensive Review.Bioengineering (Basel, Switzerland) · 2026Review
- VFLING: Vertical Federated Learning for Multi-Omics Data Integration with Graphs.Interdisciplinary sciences, computational life sciences · 2026Article
- From imaging to omics: deep learning is bridging MRI and liquid biopsy in bone tumor diagnosis.Journal of bone oncology · 2026Review
- From Prompt to Drug: Toward Pharmaceutical Superintelligence.ACS central science · 2026Review
- Big Data for Drug Discovery: Some Historical Landscape, Considerations, and Applications for a Medicinal Chemist.ACS omega · 2026Review
- Recent advancements in the application of artificial intelligence-based approaches for screening, diagnosis, prognosis and treatment of cervical cancer.Oncology reviews · 2026Review
- Study Protocol for HeartMagic: A Prospective Observational Cohort Characterizing Subtypes of Heart Failure With Preserved Ejection Fraction.Journal of the American Heart Association · 2025Article
- Artificial Intelligence in Thermal Ablation: Current Applications and Future Directions in Microwave Technologies.Biomimetics (Basel, Switzerland) · 2025Review
- Nrf2/Keap1 Signaling Axis in the Brain: Master Regulator of Oxidative Stress in Neurodegenerative and Psychiatric Disorders.Molecular neurobiology · 2025Review
- Revolutionizing multi-omics analysis with artificial intelligence and data processing.Quantitative biology (Beijing, China) · 2025Review
- Data Interoperability and Harmonization in Cardiovascular Genomic and Precision Medicine.Circulation. Genomic and precision medicine · 2025Review
- A Clinical-Radiomics Nomogram for the Preoperative Prediction of Aggressive Micropapillary and a Solid Pattern in Lung Adenocarcinoma.Current oncology (Toronto, Ont.) · 2025Article
- Machine learning-based prediction of the necessity for the surgical treatment of distal radius fractures.Journal of orthopaedic surgery and research · 2025Article
- "Voice is the New Blood": a discourse analysis of voice AI health-tech start-up websites.Frontiers in digital health · 2025Article
- Revolutionizing healthcare: the transformative potential of nanotechnology in medicine.Frontiers in drug delivery · 2025Review
- Transformer-powered precision: A DETR-based approach for robust detection in medical ultrasound with cholelithiasis as a case study.Computational and structural biotechnology journal · 2025Article
- Clinical, Cultural, Computational, and Regulatory Considerations to Deploy AI in Radiology: Perspectives of RSNA and MICCAI Experts.Radiology. Artificial intelligence · 2024Article
- Machine learning techniques to predict the risk of developing diabetic nephropathy: a literature review.Journal of diabetes and metabolic disorders · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Artificial intelligence (AI) is currently regaining enormous interest due to the success of machine learning (ML), and in particular deep learning (DL). Image analysis, and thus radiomics, strongly benefits from this research. However, effectively and efficiently integrating diverse clinical, imaging, and molecular profile data is necessary to understand complex diseases, and to achieve accurate diagnosis in order to provide the best possible treatment. In addition to the need for sufficient computing resources, suitable algorithms, models, and data infrastructure, three important aspects are often neglected: (1) the need for multiple independent, sufficiently large and, above all, high-quality data sets; (2) the need for domain knowledge and ontologies; and (3) the requirement for multiple networks that provide relevant relationships among biological entities. While one will always get results out of high-dimensional data, all three aspects are essential to provide robust training and validation of ML models, to provide explainable hypotheses and results, and to achieve the necessary trust in AI and confidence for clinical applications.
Indexed as
Identifiers
31203421What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.